AGENUS INC Cost of Goods Sold (Deprecated 2018-01-31)
AGENUS INC (AGEN) reported Cost of Goods Sold (Deprecated 2018-01-31) of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2016-03-15
- AGENUS INC cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- AGENUS INC cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $536.12K, a 20.22% decline from fiscal 2012.
- AGENUS INC cost of goods sold (deprecated 2018-01-31) for fiscal 2012 was $671.97K.
- AGENUS INC cost of goods sold (deprecated 2018-01-31) for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | |||
| 2014-09-30 | $0.00 10-Q · filed 2014-10-31 | $0.00 derived: sum of 2 quarters · filed 2014-10-31 | $0.00 10-Q · filed 2014-10-31 | $6.59K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-01 | $0.00 10-Q · filed 2014-08-01 | $6.59K derived: sum of 3 quarters · filed 2016-03-15 | $86.66K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 | $6.59K derived: sum of 2 quarters · filed 2016-03-15 | $86.66K derived: sum of 3 quarters · filed 2016-03-15 | $263.34K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2013-12-31 | $6.59K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $86.66K derived: sum of 2 quarters · filed 2016-03-15 | $263.34K derived: sum of 3 quarters · filed 2016-03-15 | $536.12K 10-K · filed 2016-03-15 | |||
| 2013-09-30 | $80.07K 10-Q · filed 2014-10-31 | -$80.07K 10-Q · filed 2013-11-08 | $256.75K derived: sum of 2 quarters · filed 2014-10-31 | $529.52K 10-Q · filed 2014-10-31 | -$529.52K 10-Q · filed 2013-11-08 | $1.57M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-06-30 | $176.68K 10-Q · filed 2014-08-01 | -$176.68K 10-Q · filed 2013-08-09 | $449.46K 10-Q · filed 2014-08-01 | -$449.46K 10-Q · filed 2013-08-09 | $1.49M derived: sum of 3 quarters · filed 2015-03-16 | $1.27M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-03-31 | $272.78K 10-Q · filed 2014-05-09 | -$272.78K 10-Q · filed 2013-05-10 | $1.31M derived: sum of 2 quarters · filed 2015-03-16 | $1.10M derived: sum of 3 quarters · filed 2015-03-16 | $968.43K derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $824.13K derived: sum of 2 quarters · filed 2015-03-16 | $695.65K derived: sum of 3 quarters · filed 2015-03-16 | $671.97K 10-K · filed 2015-03-16 | |||
| 2012-09-30 | -$217.19K 10-Q · filed 2013-11-08 | $217.19K 10-Q · filed 2012-11-07 | -$345.66K derived: sum of 2 quarters · filed 2013-11-08 | -$369.34K 10-Q · filed 2013-11-08 | $369.34K 10-Q · filed 2012-11-07 | -$369.34K derived: sum of 4 quarters · filed 2014-03-07 | |
| 2012-06-30 | -$128.47K 10-Q · filed 2013-08-09 | $128.47K 10-Q · filed 2012-08-08 | -$152.15K 10-Q · filed 2013-08-09 | $152.15K 10-Q · filed 2012-08-08 | -$152.15K derived: sum of 3 quarters · filed 2014-03-07 | -$152.15K derived: sum of 4 quarters · filed 2014-03-07 | |
| 2012-03-31 | -$23.68K 10-Q · filed 2013-05-10 | $23.68K 10-Q · filed 2012-05-09 | -$23.68K derived: sum of 2 quarters · filed 2014-03-07 | -$23.68K derived: sum of 3 quarters · filed 2014-03-07 | -$23.68K derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-07 | $0.00 derived: sum of 3 quarters · filed 2014-03-07 | $0.00 10-K · filed 2014-03-07 | |||
| 2011-09-30 | $0.00 10-Q · filed 2011-11-04 | $0.00 derived: sum of 2 quarters · filed 2011-11-04 | $0.00 10-Q · filed 2011-11-04 | $0.00 derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-05 | $0.00 10-Q · filed 2011-08-05 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | $65.05K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $65.05K derived: sum of 3 quarters · filed 2013-03-18 | $122.95K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $65.05K derived: sum of 2 quarters · filed 2013-03-18 | $122.95K derived: sum of 3 quarters · filed 2013-03-18 | $122.95K 10-K · filed 2013-03-18 | |||
| 2010-09-30 | $65.05K 10-Q · filed 2011-11-04 | $122.95K derived: sum of 2 quarters · filed 2011-11-04 | $122.95K 10-Q · filed 2011-11-04 | ||||
| 2010-06-30 | $57.90K 10-Q · filed 2011-08-05 | $57.90K 10-Q · filed 2011-08-05 | |||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |